The health insurance sector has been facing multiple challenges from the virus crisis, but market-leading healthcare firm UnitedHealth Group (NYSE: UNH) maintained
COVID-related medical costs may weigh on UnitedHealth’s performance this year
Categories
Health Care
Infographic: Intuitive Surgical Q4 earnings results
Intuitive Surgical (NASDAQ: ISRG) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The robotic product's manufacturer reported fourth-quarter
Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%
Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the
Codexis (CDXS) may be moving closer to profitability, after beating slowdown
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by
UnitedHealth Group, Inc. (UNH) Q4 2020 Earnings Call Transcript
UnitedHealth Group, Inc. (NYSE: UNH) Q4 2020 earnings call dated Jan. 20, 2021 Corporate Participants: David S. Wichmann -- Chief Executive Officer John Rex -- Office
Infographic: UnitedHealth Group (UNH) reports Q4 2020 earnings
UnitedHealth Group Incorporated (NYSE: UNH) reported fourth-quarter 2020 earnings results today. Revenues grew 7% to $65.5 billion year-over-year, helped by 21% growth
Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso
Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused by a
Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch
Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the early-stage trials
Rite Aid (RAD) looks to regain lost ground with new rebound strategy
Rite Aid Corporation (NYSE: RAD) is on a mission to put the house in order and achieve sustainable profitability, after prolonged volatility
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Special Projects
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Special
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive
Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission
Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the European Commission
COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge
Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one of the
Neogen Corp. (NEOG) Q2 2021 Earnings Call Transcript
Neogen Corp. (NASDAQ: NEOG) Q2 2021 earnings call dated Dec. 22, 2020 Corporate Participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
Rite Aid Corporation (RAD) Q3 2021 Earnings Call
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse — Senior Vice President, Investor Relations and
Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor Relations and